VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+5.4%
5Y CAGR+34.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+5.4%/yr
vs +26.9%/yr prior
5Y CAGR
+34.2%/yr
Recent deceleration
Acceleration
-21.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $51.97M | +32.0% |
| 2025 | $39.38M | +96.7% |
| 2024 | $20.02M | -54.9% |
| 2023 | $44.38M | +25.3% |
| 2022 | $35.41M | +196.9% |
| 2021 | $11.93M | -10.5% |
| 2020 | $13.33M | -22.1% |
| 2019 | $17.10M | +120.3% |
| 2018 | $7.76M | +49.2% |
| 2017 | $5.20M | - |